Insight Molecular Diagnostics, Inc. (IMDX)
2.49
+0.03
(+1.22%)
USD |
NASDAQ |
Nov 06, 16:00
2.50
+0.01
(+0.40%)
After-Hours: 20:00
Insight Molecular Diagnostics Price : 2.49 for Nov. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 06, 2026 | 2.46 | 2.70 | 2.425 | 2.49 | 94892.00 |
| Nov 05, 2026 | 2.62 | 2.62 | 2.345 | 2.46 | 147573.0 |
| Nov 04, 2026 | 2.83 | 2.99 | 2.580 | 2.65 | 154092.0 |
| Nov 03, 2026 | 2.86 | 3.12 | 2.725 | 2.74 | 113288.0 |
| Nov 02, 2026 | 2.97 | 3.03 | 2.78 | 2.86 | 127786.0 |
| Oct 30, 2026 | 3.12 | 3.15 | 2.95 | 2.96 | 62029.00 |
| Oct 29, 2026 | 3.15 | 3.20 | 3.09 | 3.18 | 111906.0 |
| Oct 28, 2026 | 3.10 | 3.18 | 3.04 | 3.18 | 85637.00 |
| Oct 27, 2026 | 3.06 | 3.25 | 2.926 | 3.16 | 306875.0 |
| Oct 26, 2026 | 2.886 | 3.025 | 2.77 | 3.00 | 160033.0 |
| Oct 23, 2026 | 2.84 | 2.921 | 2.76 | 2.83 | 42480.00 |
| Oct 22, 2026 | 2.94 | 2.99 | 2.75 | 2.84 | 262005.0 |
| Oct 21, 2026 | 3.04 | 3.10 | 2.89 | 3.02 | 300290.0 |
| Oct 20, 2026 | 2.96 | 3.275 | 2.96 | 3.03 | 316104.0 |
| Oct 19, 2026 | 3.01 | 3.025 | 2.78 | 2.89 | 474153.0 |
| Oct 16, 2026 | 3.07 | 3.18 | 2.89 | 3.01 | 181501.0 |
| Oct 15, 2026 | 2.81 | 3.12 | 2.79 | 3.06 | 177680.0 |
| Oct 14, 2026 | 2.98 | 3.10 | 2.75 | 2.79 | 407546.0 |
| Oct 13, 2026 | 3.16 | 3.20 | 2.942 | 2.99 | 312971.0 |
| Oct 12, 2026 | 3.35 | 3.37 | 3.13 | 3.17 | 219519.0 |
| Oct 09, 2026 | 3.29 | 3.441 | 3.19 | 3.37 | 156358.0 |
| Oct 08, 2026 | 3.44 | 3.56 | 3.08 | 3.28 | 227317.0 |
| Oct 07, 2026 | 3.35 | 3.665 | 3.26 | 3.46 | 153869.0 |
| Oct 06, 2026 | 3.73 | 3.757 | 3.19 | 3.38 | 460089.0 |
| Oct 05, 2026 | 3.44 | 3.74 | 3.17 | 3.67 | 408366.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Perspective Therapeutics, Inc. | 0.84 |
| Agenus, Inc. | 7.15 |
| Amgen, Inc. | 460.42 |
| Anika Therapeutics, Inc. | 14.55 |
| BioCryst Pharmaceuticals, Inc. | 7.69 |
Price Related Metrics
| PS Ratio | 50.46 |
| Earnings Yield | -59.65% |
| Market Cap | 81.23M |